Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma-Reference-Cited by-同舟云学术

Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma

Published:2022-03-15 Issue:7 Volume:35 Page:
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR in Biomedicine

Author:

Chawla Sanjeev¹^ORCID,Bukhari Sultan²,Afridi Omar M.²,Wang Sumei³,Yadav Santosh K.⁴,Akbari Hamed¹,Verma Gaurav⁵,Nath Kavindra¹,Haris Mohammad⁴,Bagley Stephen⁶,Davatzikos Christos¹,Loevner Laurie A.¹,Mohan Suyash¹

Affiliation:

1. Department of Radiology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

2. Rowan School of Osteopathic Medicine at Rowan University Voorhees New Jersey USA

3. Department of Cardiology Lenox Hill Hospital, Northwell Health New York New York USA

4. Laboratory of Functional and Molecular Imaging, Sidra Medicine Doha Qatar

5. Department of Radiology Icahn School of Medicine at Mount Sinai New York USA

6. Department of Hematology‐Oncology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

Funder

Penn Center for Precision Medicine, University of Pennsylvania

Perelman School of Medicine, University of Pennsylvania

Publisher

Wiley

Subject

Spectroscopy,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nbm.4719

Reference149 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

2. Current Therapeutic Strategies for Glioblastoma

3. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution

4. Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide

5. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging and Liquid Biopsy for Distinguishing True Progression From Pseudoprogression in Gliomas, Current Advances and Challenges;Academic Radiology;2024-08

2. Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine;Current Oncology Reports;2024-07-16

3. A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors;EJNMMI Research;2024-02-02

4. Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous;NMR in Biomedicine;2024-01-11

5. Downfield Proton MRSI at 3 Tesla: A Pilot Study in Human Brain Tumors;Cancers;2023-08-29